RoxyBond FDA Approval History
FDA Approved: Yes (First approved April 20, 2017)
Brand name: RoxyBond
Generic name: oxycodone hydrochloride
Dosage form: Tablets
Company: Protega Pharmaceuticals LLC
Treatment for: Pain
RoxyBond (oxycodone hydrochloride) is an immediate-release, abuse-deterrent, narcotic analgesic formulation for the management of severe pain.
Development timeline for RoxyBond
| Date | Article |
|---|---|
| Apr 26, 2017 | Approval Inspirion Delivery Sciences Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate Release Tablets with Abuse-Deterrent Label Claims |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
